Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:decitabine
|
| gptkbp:approvalYear |
2006
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA |
| gptkbp:ATCCode |
L01BC08
|
| gptkbp:CASNumber |
2353-33-5
|
| gptkbp:chemicalClass |
antiviral drug
|
| gptkbp:form |
injectable powder
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dacogen
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Eisai_Inc.
|
| gptkbp:mechanismOfAction |
DNA hypomethylation
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:anemia
fever nausea vomiting fatigue neutropenia thrombocytopenia |
| gptkbp:UNII |
996XVD7089
|
| gptkbp:usedFor |
gptkb:acute_myeloid_leukemia
myelodysplastic syndromes |
| gptkbp:bfsParent |
gptkb:decitabine
|
| gptkbp:bfsLayer |
8
|